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Summary
Objective: To assess the rate of successful antiepileptic drug (AED) discontinuation,
prognostic factors and proper time of AED withdrawal after surgery for medial
temporal lobe epilepsy (MTLE).
Methods: We reviewed 171 consecutive patients who underwent resective surgery for
MTLE. All patients were followed up for more than two postoperative years. AEDs
were slowly tapered with an individualized schedule for each patient. Outcome status
was determined from medical records and telephone interviews.
Results: 41.2% of patients experienced no seizure recurrence. 34.5% discontinued
medication without seizure recurrence for more than 2 years at final assessment.
Multivariate analysis revealed that an age greater than 30 years at surgery and
postoperative AED reduction before 10 months increased the risk of recurrence
[hazard ratio (HR) 2.1, 95% confidence interval (CI) 1.1—3.9 and HR 2.5, CI 1.1—5.8].
Conclusions: Resective surgery for MTLE brings seizure remission without AED to one-
third of patients. Postoperative AED tapering is recommended after at least 10
months. Younger age at surgery is a good predictive factor of remission after MTLE
surgery.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +82 2 20722923;
fax: +82 2 36727553.
E-mail address: sangunlee@dreamwiz.com (S.K. Lee).
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doi:10.1016/j.seizure.2007.05.014Introduction
Medial temporal lobe epilepsy (MTLE) is the most
common form of partial epilepsy in adults, and. Published by Elsevier Ltd. All rights reserved.
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performed epilepsy surgery. Long-term seizure-free
rates after anterior temporal lobectomy for MTLE
range from 55 to 80%, according to definitions used
and follow-up duration.1—4 However, little informa-
tion is available regarding antiepileptic drug (AED)
withdrawal after successful surgery. Successful AED
discontinuation rates have been reported to range
from 10 to 45%,4—7 with different AED withdrawal
policies. In medically treated epilepsy patients, a
minimum 2-year seizure-free period is generally
recommended before AED withdrawal.8 We attempt
withdrawal earlier in children with an epileptic
syndrome known to have a favorable prognosis.
On the other hand, for surgically treated epilepsy
patients, no guidance is available regarding
required seizure-free times before AED withdrawal.
Surgically treated patients may require shorter sei-
zure-free intervals because the epileptogenic focus
was removed. In the present study, we purposed to
deduce the proper timing for AED withdrawal and to
elucidate the effects of presurgical laboratory find-
ings and clinical settings on AED withdrawal out-
comes, in a homogeneous group of patients who
received epilepsy surgery for MTLE.Patients
We reviewed consecutive patients who were proven
to have MTLE and received anterior temporal lobect-
omy, includingamygdalohippocampectomy,between
January 1994andApril 2002.MTLEwas diagnosed; (1)
whenhippocampal sclerosisor anotherdefinite lesion
was exclusively located inside the collateral sulcus,
and (2) when an anterior temporal ictal onset was
identified by video-EEG monitoring. Patients with
neocortical lesions or bilateral hippocampal sclerosis
were excluded. Patients with critical incongruent
ictal semiology or ictal EEG findings were also
excluded.Onehundred seventy-onepatients fulfilled
the inclusion criteria, and all patients were followed
up for more than 2 years postoperatively. Patients
were identified from a computerized database con-
taining information on all patients those underwent
epilepsy surgery at Seoul National University Com-
prehensive Epilepsy Center.
Data collection and neurosurgery
Clinical parameters included age at nonfebrile-sei-
zure onset and at surgery, duration of epilepsy,
seizure frequency, number of AEDs, and history of
febrile convulsion.
All patients received video-EEGmonitoring, brain
magnetic resonance imaging (MRI) including 3 mmsections perpendicular to the long axis of the hip-
pocampus, F-18 fluorodeoxyglucose positron emis-
sion tomography (PET), ictal and interictal single
photon emission computed tomography (SPECT), if
possible, and the Wada test.
All patients with hippocampal sclerosis under-
went anterior temporal lobectomy to an extent of
3.5 cm for the left and 4.5 cm for the right, with
amygdalohippocampectomy. Some patients with
other lesions received lesionectomy with hippocam-
pectomy and anterior temporal lobectomy of vari-
able extent.
Gross and microscopic tissue analyses were per-
formed in all cases. Hippocampal sclerosis was
defined as >50% neuronal loss in CA1.
Clinical parameters, presurgical evaluations,
i.e., the presence of hippocampal sclerosis on
MRI, contralateral spikes on EEG, and contralateral
localization on SPECT or PET, were considered as
potential prognostic factors.
Postoperative antiepileptic medication
The policy for postoperative antiepileptic medica-
tion was maintenance of preoperative medication
for more than onemonth, and then AEDs were slowly
tapered, with an individualized schedule for each
patient. We included unscheduled arbitrary AED
reductions in the analysis.
Postoperative follow-up and outcome
classification
Data collected included seizure recurrence, time of
recurrence, and AED medication details. Surgical
outcomes for 1 year at the final assessment were
graded using the Engel classification; class I was
divided into seizure-free with AED and seizure-free
without AED. The classification ‘‘seizure-free with-
out AED’’ was defined as the absence of seizure for
more than 2 years without medication. Seizure out-
comes for the entire follow-up period were classi-
fied as: (1) seizure free, (2) aura only, (3) seizure
recurrence, and (4) reoperation. The information
was collected from hospital charts and outpatient
medical records and was supplemented by tele-
phone contact for the latest follow-up.
Statistical analyses
Data were analyzed using SPSS ver. 11.0. The x2 test
was used for categorical variables. The influences of
potential predictive factors on postoperative recur-
rence were evaluated by univariate and multivari-
ate Cox regression analysis. Hazard ratios (HR) are
presented with 95% confidence intervals (CI). Times
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were plotted as a Kaplan—Meier curve.Figure 1 Seizure outcomes: (A) seizure outcome
throughout postoperative follow-up period, and (B) sei-
zure outcome for last 1 year by Engel’s classification.Results
Patient characteristics
Mean age at surgery was 29.0 (9—55) years, and
mean duration of epilepsy prior to surgery was
15.4  8.63 (standard deviation) years. Preopera-
tive seizure frequency was 7.51  16.9 per month.
Fifty-eight percent of patients had a history of
febrile convulsions. All except eight (4.7%) patients
had unilateral hippocampal sclerosis by MRI. Patho-
logically determined lesions in these eight patients
were; two cavernous angiomas, three dysembryo-
plastic neuroepitheliomas, two gangliogliomas, and
one choroid plexus papilloma (Table 1).
Seizure outcome
The mean postoperative follow-up period was
69.0  28.9 months. Seventy (41.2%) patients
experienced no seizure recurrence or aura through-
out postoperative follow-up, and 18 (10.6%)
patients experienced only aura, 80 (47.1%) patients
had one or more seizure; and two (1.2%) patients
underwent further operations because of frequent
seizures (Fig. 1A). One patient had somniloquy-like
episodes that were not identified. Final seizure
outcomes for 1 year according to Engel’s classifica-
tion, were as follows: 124 (72.5%) patients achievedTable 1 Clinical characteristics of the patients
Age (year) 29.0  8.63 (S.D.)
30 42.1%
<30 57.9%
Duration of epilepsy (year) 15.4  8.63 (S.D.)
20 26.9%
<20 73.1%
Seizure frequency (/month) 7.51  16.9 (S.D.)
History of febrile convulsions 58.0%
Number of AEDs 1 = 15.8%
2 = 52.6%
3  31.6%
MRI Hippocampal sclerosis:
163 (95.3%)
Other lesions: 8 (4.7%)
Pathology Hippocampal sclerosis
Others: 2 CA, 3 DNET,
2 GGL, 1 Choroid
plexus papilloma
CA: cavernous angioma, DNET: dysembryoplastic neuroepithe-
lial tumor, and GGL: ganglioglioma.a class I outcome, 29 (17.0%) a class II outcome, 11
(6.4%) a class III outcome, and 7 (4.1%) a class IV
outcome. 59 (34.5%) patients discontinued antiepi-
leptic drugs and did not experience seizure recur-
rence for more than 2 years (Fig. 1B).
AEDs were tapered in 124 and discontinued in 79
seizure- and aura-free patients. 50 of these 124
(40.3%) patients experienced seizure recurrence
for mean follow-up period of 40.1  33.0 months
since initial AED reduction. After AED discontinua-
tion, seizures recurred in 15 of the 79 (19.0%)
patients for mean follow-up period of 49.6  29.9
months. Of these 15 patients, one patient later
achieved a seizure free state for 44 months after
re-discontinuing AEDs and six achieved a seizure-
free outcome after reintroducing AEDs. Of the
remaining eight, five achieved an outcome of Engel
class II, two class III, and one class IV at final
assessment.
Mean time to initial AED reduction after surgery
was 7.76  6.42 (mean  S.D.) months, and mean
time to discontinuation was 22.8  13.8 months.
Time of recurrence
First recurrences occurred during the postoperative
hospitalization period in 23 (23.2%) patients, during
the first postoperative year in 44 (44.4%), the second
year in 14 (14.1%), the third year in seven (7.1%), the
fourth year in one (1.0%), the fifth year in five
(5.1%), and after the fifth year in five (5.1%) patients
(Fig. 2).
Prognostic factors associated with AED
withdrawal
Univariate Cox regression analysis was used to
evaluate risk factors of recurrence. Patients older
than 30 tended to develop recurrences ( p = 0.078).
Preoperative duration of epilepsy, seizure fre-
quency, a history of febrile convulsions, and
14 S.-Y. Lee et al.
Figure 2 Time to first recurrence.number of medications were not found to predict
outcome. Hippocampal sclerosis or other patholo-
gies did not affect the outcome. Contralateral
interictal spikes were present in 26.3% of patients
preoperatively but were not found to be associated
with recurrence after AED withdrawal. Ictal SPECT
falsely localized lesions to the contralateral side in
nine (8.11%) patients, and seven of these had no
relapse. PET showed reduced uptake in the con-
tralateral side in four (2.5%) patients. Of these
four, one patient discontinued AEDs without recur-
rence, whereas the other three developed seizure
recurrence after AED tapering/discontinuation,
with final outcomes of Ia, III, IV. In terms of timeTable 2 Factors predicting recurrence after AED withdraw
Variable P va
Age 30 years 0.07
Duration of epilepsy 20 years 0.67
Seizure frequency 0.81
History of febrile convulsions 0.86
AED = 1 (reference)
AED = 2 0.41
AED  3 0.56
MRI hippocampal sclerosis 0.91
EEG–—contralateral interictal spike 0.77
Ictal SPECT–—contralateral localization 0.33
PET–—contralateral localization 0.66
Time to decreasing <10 m 0.07
Time to discontinuation <24 m 0.31
Table 3 Factors predicting recurrence after AED withdraw
Variable P value
Age >30 years 0.018
Time to decreasing AED < 10 m 0.031
Number of preoperative AEDs
AED = 1 (reference)
AED = 2 0.425
AED  3 0.171between surgery and AED withdrawal, AED taper-
ing before 10 months had lapsed after surgery
tended to evoke recurrence ( p = 0.075), but the
time to AED discontinuation did not (Table 2). AED
tapering before or after other time points had no
statistically meaningful effect.
Because time to AED tapering was possibly
affected by the number of AEDs administered,
we put two potential risk factors from the univari-
ate analysis (age at surgery, time to decreasing
AED) and the number of AEDs to multivariate Cox
regression analysis. An age greater than 30 years at
surgery and AEDs tapering before 10 months post-
operatively were found to significantly increase the
risk of recurrence ( p = 0.018 and 0.031) with
respective hazard ratios of 2.11 (95% CI 1.1—3.9)
and 2.51 (95% CI 1.1—5.8) (Table 3 and Fig. 3). No
significant differences in terms of recurrence were
observed when other time points were examined.
Time to AED discontinuation was not found to be a
risk factor of recurrence also in multivariate
analysis.
AED tapering before postoperative10 months did
not significantly affect outcome at final follow-ups
(Chi-square, p = 0.347) or 5-year postoperative out-
comes (Chi-square, p = 0.450), and neither did it
affect final success after AED discontinuation (Chi-
square, p = 0.503)al, univariate analysis
lue HR 95% CI
8 1.714 0.942—3.119
8 0.868 0.446—1.692
9 0.996 0.964—1.029
3 1.055 0.575—1.934
4 1.447 0.65—1.82
6 0.743 0.34—1.11
4 0.925 0.223—3.830
7 1.109 0.541—2.276
2 0.491 0.116—2.069
6 1.368 0.33—5.73
5 2.988 0.894—9.986
2 0.480 0.115—1.993
al, multivariate analysis
Hazard ratio 95% Confidence interval
2.111 1.139—3.911
2.512 1.055—5.801
1.450 0.582—3.610
0.405 0.215—1.712
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Figure 3 Survival curves according to risk factors of
recurrence: (A) age at surgery. An age>30 years increased
the risk of recurrence [HR 2.11 (95% CI 1.1—3.9)], and (B)
the effect of time to AED tapering on recurrence. AED
tapering before 10 months postoperatively increased the
risk of recurrence [HR 2.51 (95% CI 1.1—5.8)].Success of AED withdrawal after seizure
recurrence
Among the patients with aura or rare seizures after
surgery, AED tapering was attempted in 45 patients
and AED discontinuation in 33. Of the 33, 14 (42.4%)
patients achieved a seizure-free outcome over a
follow up of at least 2 years.Table 4 Final outcome by Engel classification after AED w
Aura before
AED change
(N = 15)
Seizure before
AED change
(N = 13)
Ia without AED (>2 year) 5 2
Ib without AED (>2 year) 1
Ia with AED 3 4
Ib with AED 4 2
II without AED 1
II with AED 2 4
III with AED
IV with AEDTwenty-eight of the 45 patients experienced aura
or seizure before initial AED reduction (Table 4).
Recurrences in these 28 patients occurred at 0—14
months postoperatively (mean 1.96 months). All
except two patients had aura or a single seizure
before AED withdrawal, and all seizures were unpro-
voked. Of the 15 patients who experienced aura
only, six successfully discontinued AEDs eventually,
and these six included one patient with persistent
aura but no seizure without AEDs for more than 2
years. For 13 patients who experienced seizure
recurrence, AED tapering was attempted after a
seizure-free period. Two of these patients suc-
ceeded in discontinuing AEDs. Two patients who
had several seizures have been seizure-free for
the AED reduction period more than 2 years.
We attempted to identify factors that affected
AED withdrawal success after seizure recurrence
unrelated with AED withdrawal, but failed to iden-
tify any prognostic factor among; time to recur-
rence, interval between recurrence and AED
reduction, age, duration of epilepsy, number of
AEDs, seizure frequency, febrile convulsions, hippo-
campal sclerosis, PET and SPECT findings, and the
presence of interictal spikes. AED discontinuation
success rates were not different for patients
who experienced a seizure during the immediate
postoperative period and those with later onset
seizures.
We reattempted AED reduction after a seizure-
free period in 17 patients who had been seizure free
initially but who developed recurrence (aura in 4
and seizure in 13) after AED reduction. Seven of
these patients have maintained a seizure-free state
for more than 2 years since AED discontinuation
(Table 4).Discussion
AED withdrawal has been extensively studied in
medically treated patients. The Medical Researchithdrawal despite aura or seizure recurrence
Aura after decreasing
AED! retry of
decreasing AED (N = 4)
Seizure after decreasing
AED! retry of
decreasing AED (N = 13)
1 6
1
4
1
2 1
1
1
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(1991) performed a randomized study on AED with-
drawal after a seizure-free period of more than 2
years and suggested that age, multiple AEDs, a
shorter seizure-free period, and EEG during the
previous year are risk factors for relapse after
AED discontinuation.9 Several other studies on
medically treated patients also concluded a lower
relapse rate after a longer seizure-free period.9—11
However, the proper time to withdraw AEDs after
surgical treatment has not been extensively stu-
died. One report concluded that postoperative sei-
zure-free duration and seizure recurrence after AED
withdrawal are unrelated. In this study, time
between surgery and AED discontinuation was 2—6
years.5 Another uncontrolled study compared AED
discontinuance after a minimum seizure-free period
of 2 years with AEDmaintenance in TLE patients, but
found no significant difference between two groups
in terms of recurrence. It suggested that AED dis-
continuation after a seizure-free period of 2 years is
safe.4 Surgically treated patients and medically
treated patients differ fundamentally because the
epileptogenic lesion is removed by surgery, and
because the surgical procedure itself may induce
seizure development. Our findings that tapering
AEDs before 10 postoperative months have lapsed
increases the risk of recurrence, but that time to
AED discontinuation is unrelated to recurrence may
be due to high recurrence rates during the early
postoperative period.
Numbers of AEDs administered has two contra-
dictory implications, i.e., it may reflect preopera-
tive disease severity and a protective effect against
recurrence during the early postoperative period,
considering that preoperative medications were
maintained for immediate postoperative period.
Age at surgery, has been identified as a prognostic
factor in surgically treated MTLE patients by a
number of previous studies.12—14. These studies
found that epilepsy duration is unrelated to recur-
rence, which concurs with our findings. These obser-
vations probably reflect the progressive nature of
MTLE. In the present study, 95.3% of patients had
hippocampal sclerosis, which is known to have a
latent period before seizure development after an
early insult.15 According to imaging studies, hippo-
campal sclerosis and cortical atrophy progress with
age,16,17 and a histologic analysis revealed that the
type of neuronal damage depends on age.18 Neuro-
nal kindling and secondary epileptogenesis could
explain a higher rate of recurrence after AED with-
drawal in older patients.
The concordance rates of PET or ictal SPECTwith
epileptogenic lesions in temporal lobe epilepsy are
about 88 and 77% respectively.19 PETshows cerebralmetabolism in the interictal state. PET is inade-
quate for ictal imaging because it takes one hour
for the radiotracer to be metabolized and distrib-
uted throughout brain tissue. If radiotracer is
injected during a seizure, results can be confusing.
The false lateralizing rate of ictal SPECT in temporal
lobe epilepsy is about 7%.20 Ictal SPECT can show
sites of secondary seizure spread depending on the
timing of radiotracer injection, rather than another
epileptic focus.
Two of four patients who showed contralateral
decreased metabolism by PET experienced poor
outcomes. Contralateral localization by ictal SPECT
or presence of contralateral interictal spike was not
found to affect outcome. Our results show that
contralateral PET localization might be meaningful
in terms of anticipating seizure recurrence after
AED reduction.
The presence of interictal epileptic discharges
(IEDs) in both temporal lobes appeared to increase
the likelihood of seizures arising independently from
either side,21 and a review of an autopsy series of
patients with temporal lobe epilepsy found that up
to 90% of patients had bitemporal damage.22 Several
studies on surgical outcome in TLE have concluded
that unilateral temporal epileptiform discharges are
associated with a good prognosis,13,14 but other
studies failed to find that contralateral IEDs are
related to surgical outcome.23,24 In our series,
because a multidisciplinary approach to epileptic
focus determination using MRI, ictal EEG, PET and
ictal SPECT might exclude multifocal epilepsy, the
presence of IEDs is insufficient to predict residual
epileptogenic foci, even when AEDs are completely
withdrawn.
Hippocampal sclerosis has been reported to be
unfavorable pathology with respect to surgical out-
come as compared with small tumors or cavernous
angiomas.23 In the present study, comparison
between pathologies was not possible because
95.3%of patients enrolledhadhippocampal sclerosis.
A preoperative history of febrile convulsion was
not found to be related to AED discontinuation
related outcome, which is consistent with the find-
ings of other studies.
Seizure recurrence mechanisms can be explained
by residual epileptogenic lesions and surgery-
related epileptogenicity. Surgically treated patients
commonly experience seizures during the first few
months or years, but these finally remit. Rasmussen
described this as a ‘‘running-down phenomenon’’
and postulated that the hard-core, lowest-thresh-
old, epileptogenic area is removed at surgery, and
that minimal residual epileptogenic tissues are
insufficient to generate seizures indefinitely.13 In
addition, it is generally believed that epileptic
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period, like those that follow trauma and stroke, do
not necessarily predict long-term outcome after
resection,25 although findings are conflicting. Acute
postoperative seizures (APOSs) are believed to be an
effect of surgical injury, and have been described as
neighborhood seizures,26 and are frequently
observed after temporal lobectomy.27 A study of
frontal lobe epilepsy surgery found that APOSs dur-
ing the first postoperative week were unrelated to
seizure-free outcome.28 However, studies on tem-
poral lobe epilepsy suggest that APOS is associated
with an unfavorable outcome.26,29,30 Another study
found that early postoperative recurrence, includ-
ing recurrences within one week, is associated with
intractability and that later recurrences were sel-
dom intractable.31 Most late recurrences that occur
during the AED tapering period can be treatable by
increasing or reintroducing AEDs, but early seizures
not associated with AED tapering may not respond to
AEDs. However, in terms of curability, late recur-
rences associated with AED tapering may indicate a
less favorable outcome with respect to AED discon-
tinuation, whereas early seizures have a chance of
cure after a running-down period.
Early seizure recurrences are of three types: (1)
surgical failures, i.e., due to a residual primary
epileptogenic lesion; (2) those destined to run
down, i.e., residual lesions with low epileptogenic
potential; and (3) acute transient postoperative
seizures associated with surgical injury. The differ-
entiation of these three types is helpful for planning
AED withdrawal, but such differentiations are
uncertain. In the present study, AED withdrawal
was performed in only 45 patients that experienced
recurrence, and we were unable to identify predic-
tors of outcome. Seizure similarity with habitual
seizures has been suggested to predict persistent
seizures by some26,31 but not by others.29 In the
present study, no analysis of type of recurrent sei-
zure was performed because outpatient interviews
without video-EEG monitoring have limitations for
seizure classification.
Late seizures unassociated with AED tapering are
believed to be due to maturation of secondary
epileptogenic lesion and resection scars.31 In our
series, three patients who were seizure-free before
AED discontinuation had unfavorable outcomes
despite AED reintroduction.
Final outcomes were not dependent on time to
AED reduction. Early AED tapering induced more
recurrences but did not affect long-term outcome
or the success of AED discontinuation. This observa-
tion suggests that sufficient AEDs are needed during
the early postoperative period to protect against
the relatively high risk of seizure recurrence, butthat early AEDs cannot prevent epileptogenesis. In
spite of that, an initial AED maintenance period is
required to prevent early seizures and allow obser-
vation of surgical results. Based on our results,
postoperative AED tapering is recommended after
at least 10 months. Longer periods until AED reduc-
tion are likely to be safer because first recurrence is
not infrequent after 1 year. Further controlled study
is required to determine the optimum period.References
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